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Abstract
Cutaneous leishmaniasis is usually transmitted by infected phlebotomine sand fly bites that initiate local cutaneous lesions. Few 
reports in the literature describe other modes of transmission. We report a case of a previously healthy 59-year-old woman who 
underwent electrocoagulation to remove seborrheic keratosis confirmed by dermatoscopy. Three months later, a skin fragment 
tested positive for Leishmania culture; the parasite was identified as L. (V.) braziliensis. Trauma may generate inflammatory 
cascades that favor Leishmania growth and lesion formation in previously infected patients. American cutaneous leishmaniasis 
is a dynamic disease with unclear pathophysiology because of continually changing environments, demographics, and human 
behaviors. 
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INTRODUCTION
Cutaneous leishmaniasis (CL) is an endemic infectious 
disease, representing a large public health problem worldwide1. 
In Brazil, an average of 30,000 cases are reported annually. 
Usually, CL is transmitted by infected phlebotomine sand fly 
bites, and a subclinical infection in the host has been proven1. 
There are a few reports that describe unusual modes of parasite 
infection, such as through direct contact, rat bites, accidental 
laboratory inoculation2,3, localized trauma4,5, and the use of 
immunomodulators such as anti-tumor necrosis factor (TNF)-
alpha6,7. Here, we report a case of American tegumentary 
leishmaniasis (ATL) following electrocoagulation for a 
seborrheic keratosis skin lesion. 
CASE REPORT
A previously healthy 59-year-old female Brazilian 
biologist who often travels to ATL endemic areas underwent 
an electrocoagulation procedure to remove two hyperchromic 
squamous stable lesions, that appeared after 50 years of age, 
when the patient was no longer traveling to endemic areas. 
Clinically and dermoscopically, both lesions were diagnosed 
as seborrheic keratosis: one on the nose and the other on the 
thigh. Two months later, with no reported travel to endemic 
ATL regions, erythematous nodules emerged on the surgical 
scars. One month later, the nodules were removed and sent 
for histopathology, fungal, bacterial, and mycobacterial 
direct examinations and cultures, which were reported to be 
negative. Only 6 months later and after the third biopsy, the 
histopathology showed a lymphohistiocytic infiltrate with 
granulomas and multinucleated cells, and some rare roundish 
forms compatible with amastigotes, which were confirmed 
by immunohistochemistry. A skin fragment tested positive 
for Leishmania culture, and the parasite was identified as 
L. (V.) braziliensis using a polymerase chain reaction (PCR) 
assay and restriction enzyme analysis8. Montenegro skin test 
and indirect immunofluorescence assay results were positive 
and human immunodeficiency virus (HIV) serology test results 
were negative. She was treated with 2g of liposomal 
amphotericin B and had completely healed by the time of this 
report (Figure 1 and Figure 2).
DISCUSSION
Here, we reported the case of an immunocompetent patient 
with no previous sign of leishmaniasis. After undergoing a 
very common dermatological procedure for the removal of 
two well-defined benign lesions on distant parts of the body, 
after a short period of time, she presented with simultaneous 
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FIGURE 2: Complete healing after liposomal amphotericin B treatment. 
FIGURE 1: Ulcerated erythematous infiltrated plaque on the right malar and 
nose lateral region 3 months after seborrheic keratosis electrocoagulation. 
CL lesions on both sites. This presentation reinforces the idea 
that electrocoagulation may have triggered ATL. 
In the Americas, the main species that causes ATL is 
L. (V.) braziliensis8. Previous studies of Leishmania serology, 
Montenegro skin tests, and the presence of Leishmania DNA 
identified using PCR techniques have shown that in Brazilian 
endemic areas, 10% of the population has subclinical infections7. 
It is also important to note that there are some reported cases 
of primary or secondary CL lesions after localized trauma, 
and these lesions can appear months later4,5. In our experience 
of more than 2,000 cases of ATL, we have observed 3 cases 
triggered by trauma: one after a bicycle trauma on the ankle 
cause by L. (L.) amazonensis9; one after a snake bite; and one 
after a laser hair removal procedure. In addition, previous 
studies in murine models infected with Leishmania support the 
possibility of metastatic cutaneous lesions at sites of trauma5.
Considering the concepts presented above, we may consider 
that trauma generates an inflammatory cascade that favors 
Leishmania dissemination and lesion formation in previously 
infected patients. This hypothesis is supported by the local 
formation of immunosuppressive cytokines and transformation 
of growth factor-p that exacerbates lesion development. 
Previous studies in Balb-c mice infected with L. (V). braziliensis 
have shown that these factors could reactivate the subclinical 
infection10,11. Our patient was a biologist that lived for 9 years 
in Rio de Janeiro, Brazil, and travelled several times to endemic 
regions. She presented typical lesions of seborrheic keratosis, the 
diagnosis of which was confirmed by clinical and dermatoscopy 
examinations, and that appeared when she no longer travelled.
In this case and in others found in the literature, we note that 
the clinical presentation is usually characterized by nodules, 
plaques, and papules that are not typical unique ulcers, making 
the diagnosis even more difficult. It is important to differentiate 
this case, wherein an immunocompetent patient had a previous 
subclinical Leishmania infection, from the previously referenced 
cases in which the parasite was inoculated by agents other than 
phlebotomine sand flies2,3. It is believed that disease activation 
was triggered by the electrocoagulation procedure, characterized 
as the known locus minoris resistentiae phenomenon12.
Histopathology is the gold standard examination for the 
diagnosis of seborrheic keratosis, but those lesions are a part 
of dermatologists’ daily practice; seborrheic keratosis lesions 
exhibit unique clinical characteristics, with no malignant 
potential, and are cured by electrocoagulation procedures. 
In addition, dermatoscopy examinations are also commonly 
performed.
ATL is a dynamic disease, the pathophysiology of which 
is not well understood because of the continually changing 
environmental, demographic, and human behavioral factors. It 
is important for all physicians to be aware of the possibility of 
CL lesion onset at the sites of dermatological and aesthetical 
procedures in endemic and nonendemic areas, as the world 
is globalized and leishmaniasis is considered a re-emerging 
disease.
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